Vol 2008, No 94 (2008)

Table of Contents

Cartoons

Removals jpg
Business Review Editor

Deal Trackers

Bifeprunox Abstract pdf
Business Review Editor

Research & Development

Regulus' microRNA Proves Attractive to GSK Abstract pdf html
Sally Mardikian PhD

Features

Pfizer's Changing Strategy Abstract pdf
Business Review Editor
Roche - Still One Step Ahead? Abstract pdf
Business Review Editor
Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector: a review of a recently published report Abstract pdf
Business Review Editor
Therapy Focus - Type 1 Diabetes, the Latest Developments Abstract pdf
Business Review Editor

Licensing

Dyax and Cubist Sign Deal for DX-88 Surgical Indications Abstract pdf html
Helen Scrutton
Astellas and CoMentis Enter into Deal for Novel Alzheimer's Drug Abstract pdf html
The PharmaDeals Team
Endo In-licenses Novartis Pain Product Abstract pdf
Business Review Editor
Amgen Licenses Monoclonal Antibody from Kyowa Kakko Abstract pdf
Business Review Editor

General

Effective Benchmarking Abstract
Business Review Editor
Merz Pharmaceutical GmbH Abstract
Business Review Editor

Mergers & Acquisitions

GSK Enters into Sirtuin Field with Latest Acquisition Abstract pdf html
Sally Mardikian PhD
UK Spin-off Acquired by Roche for Multi-Million Figure Abstract pdf html
Sally Mardikian PhD
Takeda Strengthens Foothold in US Abstract pdf html
Sally Mardikian PhD
Dr. Reddy's Acquisition Sweeps through Europe Abstract pdf html
Sally Mardikian PhD
EUSA Pharma to Acquire Cytogen Abstract pdf
Business Review Editor
Galderma Acquires CollaGenex Abstract pdf
Business Review Editor

Business Commentaries

The Times They Are A-Changing Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.